Literature DB >> 28444346

Resistant starch as a novel dietary strategy to maintain kidney health in diabetes mellitus.

Gar Yee Koh1, Matthew J Rowling1.   

Abstract

The worldwide prevalence of diabetes mellitus is expected to reach 439 million by 2030. Diabetes increases the risk for developing secondary complications such as nephropathy and cardiovascular disease, critical factors that dictate the survival rate of diabetes patients. Compelling evidence has indicated that the positive impact of fermentable carbohydrates in obesity-related diabetes is mediated by the production of short-chain fatty acids and the modulation of colonic microbiota. This review summarizes the potential implications of dietary resistant starch, a class of fermentable fiber, in glucose homeostasis and kidney health in obesity-associated diabetes and examines the mechanisms underlying the protective effect of resistant starch. Though extensive clinical studies are still warranted, replacement of simple carbohydrates with resistant starch could be a highly effective alternative dietary strategy to prevent secondary complications resulting from hyperglycemia.
© The Author(s) 2017. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  diabetic nephropathy; gut microbiota; resistant starch; type 2 diabetes; vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28444346     DOI: 10.1093/nutrit/nux006

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  3 in total

Review 1.  Novel treatment strategies for chronic kidney disease: insights from the animal kingdom.

Authors:  Peter Stenvinkel; Johanna Painer; Makoto Kuro-O; Miguel Lanaspa; Walter Arnold; Thomas Ruf; Paul G Shiels; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2018-01-15       Impact factor: 28.314

Review 2.  Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.

Authors:  Esmeralda Castillo-Rodriguez; Raul Fernandez-Prado; Raquel Esteras; Maria Vanessa Perez-Gomez; Carolina Gracia-Iguacel; Beatriz Fernandez-Fernandez; Mehmet Kanbay; Alberto Tejedor; Alberto Lazaro; Marta Ruiz-Ortega; Emilio Gonzalez-Parra; Ana B Sanz; Alberto Ortiz; Maria Dolores Sanchez-Niño
Journal:  Toxins (Basel)       Date:  2018-07-19       Impact factor: 4.546

3.  Suppression of HDAC2 by sodium butyrate alleviates apoptosis of kidney cells in db/db mice and HG‑induced NRK‑52E cells.

Authors:  Yi Du; Gang Tang; Weijie Yuan
Journal:  Int J Mol Med       Date:  2019-11-06       Impact factor: 4.101

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.